Search Within

Thomas Kaley

Formats
  1. Meeting Abstract (87)
  2. Journal Article (55)
  3. Book Section (6)
  4. Review (4)
  5. Guidelines (3)
  6. Research Letter (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (63)
  2. GSK Faculty (55)
  3. Human Oncology and Pathogenesis Program (50)
  4. Radiology, Department of (42)
  5. Neuroradiology Service (40)
  6. Department of Medicine (33)

More Groups

People
  1. Ingo Mellinghoff (46)
  2. Lisa De Angelis (46)
  3. Antonio Omuro (38)
  4. Igor Gavrilovic (35)
  5. Elena Pentsova (34)
  6. Craig Nolan (31)

More People

Years
  1. 2025 (3)
  2. 2024 (8)
  3. 2023 (10)
  4. 2022 (9)
  5. 2021 (6)
  6. 2020 (11)

More Years

Publications
  1. Neuro-Oncology (58)
  2. Journal of Clinical Oncology (34)
  3. Clinical Cancer Research (9)
  4. Journal of Neuro-Oncology (7)
  5. Journal of the National Comprehensive Cancer Network (6)
  6. Blood (5)

More Publications

Publishers
  1. Oxford University Press (60)
  2. American Society of Clinical Oncology (36)
  3. American Association for Cancer Research (12)
  4. Springer (10)
  5. Harborside Press (6)
  6. American Society of Hematology (5)

More Publishers

Results (156)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dropped head syndrome: Report of three cases during treatment with a mek inhibitor
    Journal Article

    Chen, X.; Schwartz, G. K.; De Angelis, L. M.; Kaley, T.; Carvajal, R. D.
    Neurology (2012)

    Fulltext@MSK | Save
  • Temozolomide or bevacizumab for spinal cord high-grade gliomas
    Journal Article

    Kaley, T. J.; Mondesire-Crump, I.; Gavrilovic, I. T.
    Journal of Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Atypical and anaplastic meningiomas treated with bevacizumab
    Journal Article

    Nayak, L.; Iwamoto, F. M.; Rudnick, J. D.; Norden, A. D.; Lee, E. Q.; Drappatz, J.; Omuro, A.; Kaley, T. J.
    Journal of Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Preliminary results from a multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Quant, E. C.; Batchelor, T.; Lassman, A. B.; Schiff, D.; Kaley, T. J.; Wong, E.; Mikkelsen, T.; Drappatz, J.; Norden, A. D.; Beroukhim, R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma
    Meeting Abstract

    Norden, A. D.; Hammond, S.; Drappatz, J.; Phuphanich, S.; Reardon, D. A.; Wong, E.; Plotkin, S. R.; Lesser, G. J.; Raizer, J. J.; Batchelor, T.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Sequential treatment with temozolomide, PCV, and radiation for grade II oligodendrogliomas
    Meeting Abstract

    Graber, J. J.; Kaley, T.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Radiographic patterns of recurrence with pathologic correlation in patients with malignant gliomas treated with bevacizumab (BEV)
    Meeting Abstract

    Kaley, T. J.; Huse, J.; Karimi, S.; Rosenblum, M.; Omuro, A.; Deangelis, L. M.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus and perifosine for recurrent or progressive malignant glioma
    Meeting Abstract

    Lassman, A. B.; Kaley, T. J.; Deangelis, L. M.; Hormigo, A.; Mellinghoff, I. K.; Otap, D. D.; Seger, J.; Doyle, L. A.; Ludwig, E.; Lacouture, M. E.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Preliminary data from a multicenter, phase II, randomized, noncomparative clinical trial of radiation therapy and temozolomide with or without vandetanib in newly-diagnosed glioblastoma
    Meeting Abstract

    Lee, E. Q.; Batchelor, T. T.; Lassman, A. B.; Schiff, D. S.; Kaley, T. J.; Wong, E. T.; Mikkelsen, T.; Purow, B. W.; Drappatz, J.; Norden, A. D.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save